Supplemental Figure 1: Kaplan-Meier Curves of overall survival based on clinical stage at presentation and treatment modality Kaplan-Meier analyses depicting.

Slides:

Advertisements

Similar presentations

Prostate Cancer Int. 洪毓謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:

Advertisements

Table 1. Characteristics of patients and the results of the log-rank test of prognostic factors Median (range) No. of patients No. of CRPC Median progression.

Accelerated radical radiotherapy for Non Small Cell Lung Cancer: Single centre audit outcome of two fractionations in the treatment of the elderly patients.

From: Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrence:A Retrospective Analysis Anesthes. 2008;109(2): doi: /ALN.0b013e31817f5b73.

Volume 187, Issue 6, Pages (June 2012)

Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract Noah Switzer, Andrew Lim, Lillian Du,

Volume 155, Issue 3, Pages (March 1996)

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study Liver Cancer.

Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis Yi-Jhih.

Claude C. Schulman, Jacques Irani, Juan Morote, Jack A

Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus Yang Zhao, MD, ZhiJun Dai,

Volume 69, Issue 1, Pages (January 2016)

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk.

Advances in the Treatment of Metastatic Prostate Cancer

Volume 72, Issue 5, Pages (November 2017)

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind,

What is New in Hormone Therapy for Prostate Cancer in 2007?

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer Gaurav S. Ajmani, MHS, Chi-Hsiung.

Volume 71, Issue 5, Pages (May 2017)

Nat. Rev. Urol. doi: /nrurol

Luis Martínez-Piñeiro European Urology Supplements

Gastrointestinal Endoscopy

Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients Kaiguo Li, Ruyue Wang, Shiting Huang, Xinbin Pan, Hongmin.

The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis Annemarie T. Fernandes, BA, Eric.

Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care.

External Beam Radiotherapy as Curative Treatment of Prostate Cancer

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base Amy C. Moreno,

Volume 375, Issue 9722, Pages (April 2010)

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy

Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract Noah Switzer, Andrew Lim, Lillian Du,

Survival after resection of synchronous non–small cell lung cancer

Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E

Volume 71, Issue 3, Pages (March 2017)

Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and.

Treatment of Locally Advanced Pancreatic Cancer

Volume 49, Issue 4, Pages (April 2006)

European Urology Oncology

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Long-Term Hormonal Therapy: Who Would Benefit?

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based.

Patients represented by 441 physicians surveyed from 19 countries, depicted in the patient journey from diagnosis to ensuing treatment with ADT. ADT, androgen.

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

Clinical Lymphoma, Myeloma and Leukemia

• Kaplan-Meier analyses of (A) overall survival (OS) of the whole cohort (n=173), (B) OS from time of diagnosis of high-risk melanoma among those who remained.

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Axel Heidenreich European Urology Supplements

Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease.

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Supplemental Figure 6 Effect of p. o

Impact of a Multidisciplinary Thoracic Oncology Clinic on the Timeliness of Care Richard F. Riedel, MD, Xiaofei Wang, PhD, Meg McCormack, PA-C, Eric Toloza,

“Salvage” Surgery for Primary Mediastinal Malignancies: Is it Worthwhile? Francesco Petrella, MD, Francesco Leo, MD, PhD, Giulia Veronesi, MD, Piergiorgio.

Highlighting Unmet Needs: Real Patients, Difficult Choices

Donor Cell Leukemia: A Review

Supplementary Figure S1

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Superior sulcus lung tumors: Impact of local control on survival

Axel Heidenreich European Urology Supplements

Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung.

Figure S1. A. B. Figure S1. Kaplan-Meier curve of progression-free survival by treatment group in soluble heregulin (HRG)-high population (A) and soluble.

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

Rashed Ghandour, Nirmish Singla, Yair Lotan Trends in Cancer

A and B, The ROC curves analyzing the sensitivity and specificity of the WHO grading system (I-IV) for the 1-year survival (A) and recurrence (B) show.

European Urology Oncology

Presentation transcript:

Supplemental Figure 1: Kaplan-Meier Curves of overall survival based on clinical stage at presentation and treatment modality Kaplan-Meier analyses depicting overall survival following diagnosis of small cell carcinoma of the prostate based on (a) clinical stage at diagnosis, (b) local therapy, (c) chemotherapy, and (d) androgen-deprivation therapy. Abbreviations: CI, Confidence interval; RP, Radical prostatectomy; RT, Radiation therapy; ADT, Androgen deprivation therapy; CT, Chemotherapy; Rx, Treatment